-Elder Pharmaceuticals Limited have forfeited 59750 equity shares of the company as the allotment money on those shares were not forthcoming from the respective shareholders inspite of final reminder for payment of allotment money was sent to them.
-The out come of AGM
Decided to increase the authorized capital from from the existing Rs.12,00,00,000 (Rupees Twelve crores only) to Rs.15,00,00,000 (Rupees Fifteen crores only) by creation of 30,00,000 (Thiry Lac) new equity shares of Rs.10/- each
Appointed the following Directors namely : 1)Mr.Vijay N.Paranjpe as Joint Managing Director 2)Mr.Peter Bibby, Mr.Adil S.Kajiji,Dr.S.Jayaram & Mr.Saleem Sherwani as Independent Directors.
-Members have approved increase in authorised share capital from existing 120 million to Rs 150 million.
-Elder Pharmaceuticals forges alliance with two Spanish companies - Ferrer SA and Covex SA - for marketing and manufacturing two products in the fast growing cerebro neuropsychiatry (CNS) segment
-Enters into in-licensing agreements with two Japanese pharma companies- Tanabe Seiyaku and Fujisawa . Through these two agreements, the company procures exclusive marketing rights for two anti-hypertensive products in the Indian market
-Ties up with Reliance Life Sciences (RLS) to source aloe vera extracts for skin-related products to be developed by the company
- Joins hands with herbal beauty care specialist Shahnaz Husain for launch of Fair One, a fairness cream
-Elder Pharmaceuticals has signed a strategic marketing alliance with the Swiss pharma major TRB Chemedica to introduce a new range of osteoarthritis and pain management drugs in India
-Elder Pharma join hands with Swedish firm Sterisol AB